FDA updates EUAs for COVID-19 antigen tests, alerts providers to device recall and shortage

Nov 02, 2022 - 04:01 PM
fda-alert-recall-compounded-drugs

The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require updates to product labeling regarding serial testing. As recommended in August, the revised EUAs and labeling call for users with COVID-19 symptoms to repeat testing at least twice over three days and users without symptoms to repeat testing at least three times over five days, with at least 48 hours between tests.

In other news, the FDA yesterday designated the recall of 60,500 filters used in breathing systems a Class I recall, meaning the devices may cause serious injury or death. Teleflex recalled the Iso-Gard S filters in August. On Monday, FDA also alerted health care providers to a shortage of tracheostomy tubes, used to help people breathe after a tracheotomy, including a tube made by ICU Medical for pediatric patients. The agency recommends providers and other caregivers consider using certain conservation strategies.
 
 

Related News Articles

Headline
HHS to end emergency authorization for COVID-19 drugs, medical devices 
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
FDA recalls certain first aid kits with TRUE METRIX blood glucose devices 
The Food and Drug Administration has identified a Class I recall of North American Rescue first aid kits containing TRUE METRIX Blood Glucose Monitoring…
Headline
Highest FDA recall issued for certain catheters, heart pump controllers
The Food and Drug Administration has identified a Class I recall of reprocessed electrophysiology and ultrasound catheters by Medline Industries due…
Headline
FDA says shortage of breast biopsy needles expected to last until 2027 
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…
Headline
FDA issues alert for Abiomed heart pump controllers 
The Food and Drug Administration has issued an early alert for all heart pump controllers by Abiomed, which sent a correction notice to all customers with…
Headline
FDA issues most serious recall for certain pacemaker devices by Boston Scientific
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy…